Cencora, Inc.
COR · Healthcare · Health Care
Updated 25 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #225 of 500 by Iconic Score · #25 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Cencora Inc (COR) is a prominent player in the healthcare sector, specializing in providing comprehensive supply chain solutions and services for pharmaceutical and biotechnology companies. With a market capitalization of $59.0 billion, Cencora operates as a vital intermediary, facilitating the distribution of critical medications and therapies while ensuring compliance with regulatory standards. The company leverages advanced technology and data analytics to optimize logistics and enhance operational efficiency, positioning itself as a trusted partner in the healthcare ecosystem. Cencora's significant market presence underscores its importance in addressing the growing demand for reliable healthcare solutions, especially as the industry continues to evolve in response to emerging health challenges and innovations. Its role in streamlining access to essential therapies makes it a key contributor to improving patient outcomes and supporting the overall healthcare infrastructure.
IconicOracleAI™ Brief
Cencora Inc's Iconic Score of 49 reflects a moderate brand presence amid recent strategic moves, including the acquisition of the American Oncology Network for $2.4 billion, aimed at enhancing community oncology support. Despite a slight decline in stock price, the company's brand visibility remains strong at 75/100, indicating effective logo recognition. Overall sentiment appears stable as Cencora continues to position itself within the competitive healthcare landscape.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.